Congestive Heart Failure: Clinical Trials

29 trials for Congestive Heart Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

29 completed. 29 Phase 1, 10 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 129Completed 29
Phase 210Completed 10

Follow Congestive Heart Failure: new trials by email Literature Review of Congestive Heart Failure trials Research Report on Congestive Heart Failure

Trials (filtered) newest first · largest first

All 29 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Learn How the Study Treatment BAY1753011 Moves Into, Through and Out of the Body, How it Works, How Safe it is, and How it Affects the Body When Given Once as Tablet in Male and Female Participants With Reduced Kidney Function Compared to Matched Participants With Normal Kidney Function
Pecavaptan (BAY1753011) - Congestive Heart Failure, Renal Impairment
Phase 1CompletedBayer322019-11-252022-10-31
AB-1002 in Patients With Class III Heart Failure
3 x 10e13vg AB-1002 - Congestive Heart Failure, Heart Failure
Phase 1CompletedAskBio Inc112019-11-202026-08-06
An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function
BMS-986231 - Liver Dysfunction, Liver Insufficiency
Phase 1CompletedBristol-Myers Squibb762018-05-252020-08-27
Phase I Study of OPC-61815
OPC-61815 16mg, OPC-61815 32mg, Moxifloxacin - Congestive Heart Failure
Phase 1CompletedOtsuka Pharmaceutical Co., Ltd.482018-05-082021-05-10
Thiamine Supplementation in Heart Failure: a Pilot Randomized Controlled Crossover Trial
Thiamine, Placebo - Heart Failure, Heart Failure With Reduced Ejection Fraction
Phase 1CompletedHamilton Health Sciences Corporation242018-04-022021-08-31
A Study of Experimental Medication BMS-986231 in Patients With Different Levels of Kidney Function
BMS-986231 - Myocardial Failure, Cardiac Failure
Phase 1CompletedBristol-Myers Squibb482018-03-152019-09-11
Within Subject Variability Study of ER Torsemide 20 mg Tablet in Healthy Subjects
Demadex 20mg Tablet, ER Torsemide 20mg Tablet - Congestive Heart Failure, Chronic Kidney Diseases
Phase 1CompletedSarfez Pharmaceuticals, Inc.242017-06-192018-04-18
AiDing Diuresis wIth Tolvaptan (ADD-IT)
Tolvaptan 30 mg + IV Diuretics, Metolazone 5 mg + IV Diuretics, 2.5 times the Diuretics Dose - Cardiomyopathy, Congestive Heart Failure
Phase 1CompletedEmory University142016-01-012019-03-27
A Study Investigating the Safety, Tolerability, and Pharmacokinetics of MTP-131 in Subjects With Congestive Heart Failure
MTP-131, Placebo - Congestive Heart Failure
Phase 1CompletedStealth BioTherapeutics Inc.362014-07-012015-09-17
Autonomic Neural Regulation Therapy to Enhance Myocardial Function in Heart Failure (ANTHEM-HF) Study
Vagus Nerve Stimulation (VNS) - Congestive Heart Failure
Phase 1 / Phase 2CompletedCyberonics, Inc.602012-07-012015-02-19
Tadalafil and Nesiritide as Therapy in Pre-clinical Heart Failure
Nesiritide, Tadalafil, Placebo - Congestive Heart Failure
Phase 1 / Phase 2CompletedMayo Clinic432012-02-012018-03-22
Initial Study of Fenoterol as a Treatment for Heart Failure
Oral R,R'-Fenoterol, Oral Racemic Fenoterol - Congestive Heart Failure
Phase 1CompletedNational Institute on Aging (NIA)292011-07-102018-07-05
Retrograde Delivery of BMAC (Bone Marrow Aspirate Concentrate) for Congestive Heart Failure
BMAC infusion - Congestive Heart Failure
Phase 1CompletedHarvest Technologies302011-02-012014-08-19
Extracorporeal Shockwave Myocardial Revascularization (ESMR) Therapy For The Treatment of Chronic Heart Failure
Cardiospec - Congestive Heart Failure
Phase 1CompletedMedispec92011-01-012013-02-20
AC6 Gene Transfer for CHF
Ad5.hAC6, Sucrose (3%) - Congestive Heart Failure
Phase 1 / Phase 2CompletedHammond, H. Kirk, M.D.562010-07-012018-02-09
AutoLogous Human CArdiac-Derived Stem Cell to Treat Ischemic cArdiomyopathy (ALCADIA)
human cardiac stem cells - Congestive Heart Failure, Ischemic Cardiomyopathy
Phase 1CompletedNaofumi Takehara62010-04-012015-04-01
Cardiac Stem Cell Infusion in Patients With Ischemic CardiOmyopathy (SCIPIO)
Treatment group - Coronary Artery Disease, Congestive Heart Failure
Phase 1CompletedUniversity of Louisville332009-02-012017-04-11
Glycemic Control and Variability for Congestive Heart Failure Exacerbation
Intravenous insulin, Subcutaneous insulin - Congestive Heart Failure, Diabetes Mellitus
Phase 1 / Phase 2CompletedKathleen Dungan752009-01-012013-12-31
Autologous Mesenchymal Stromal Cell Therapy in Heart Failure
Mesenchymal stromal cell, Saline - Congestive Heart Failure
Phase 1 / Phase 2CompletedCopenhagen University Hospital, Rigshospitalet592008-09-012015-03-17
Absorption, Distribution, Metabolism and Excretion of [14C]- Labeled BIA 5-453 and Metabolites
BIA-5-453 - Hypertension, Congestive Heart Failure
Phase 1CompletedBial - Portela C S.A.42008-09-012017-01-09

Showing 20 of 29. Sign in to see all of them.

Narrower conditions

Heart Failure (29)  ·  Cardiomyopathies (2)  ·  Hypertension (2)  ·  Renal Insufficiency (2)  ·  Adenoviridae Infections (1)  ·  Anemia (1)  ·  Arrhythmias, Cardiac (1)  ·  Cardiovascular Diseases (1)  ·  Coronary Artery Disease (1)  ·  Diabetes Mellitus (1)  ·  Heart Failure, Diastolic (1)  ·  Heart Failure, Systolic (1)  ·  Hepatic Insufficiency (1)  ·  Hyperglycemia (1)  ·  Ischemia (1)

Broader conditions

Heart Diseases (29)  ·  Cardiovascular Diseases (28)  ·  Pathologic Processes (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Vascular Diseases (4)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Kidney Diseases (3)  ·  Male Urogenital Diseases (3)  ·  Urogenital Diseases (3)  ·  Urologic Diseases (3)  ·  Chronic Disease (2)  ·  Disease Attributes (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Arterial Occlusive Diseases (1)

Interventions

Natriuretic Peptide, Brain (3)  ·  Sodium Chloride (2)  ·  etamicastat (2)  ·  Coronary Artery Bypass (1)  ·  Darbepoetin alfa (1)  ·  Diuretics (1)  ·  Extracorporeal Shockwave Therapy (1)  ·  Furosemide (1)  ·  KCB-1 protein, recombinant (1)  ·  Metolazone (1)  ·  Moxifloxacin (1)  ·  Pharmaceutical Preparations (1)  ·  Sucrose (1)  ·  Tablets (1)  ·  Tadalafil (1)

Sponsors

Bial - Portela C S.A. (2)  ·  Bristol-Myers Squibb (2)  ·  Horng Chen (2)  ·  Acusphere (1)  ·  Amgen (1)  ·  AskBio Inc (1)  ·  Bayer (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Cyberonics, Inc. (1)  ·  Emory University (1)  ·  Hamilton Health Sciences Corporation (1)  ·  Hammond, H. Kirk, M.D. (1)  ·  Harvest Technologies (1)  ·  Johann Wolfgang Goethe University Hospital (1)  ·  Kathleen Dungan (1)

Countries

United States (11)  ·  Germany (3)  ·  India (3)  ·  Japan (2)  ·  Poland (2)  ·  Bulgaria (1)  ·  Canada (1)  ·  Czechia (1)  ·  Denmark (1)  ·  France (1)  ·  Hungary (1)  ·  Israel (1)  ·  Peru (1)  ·  Switzerland (1)

Top investigators

Amit Patel, MD (2)  ·  Horng H. Chen, M.D. (2)  ·  Andreas M Zeiher, MD (1)  ·  Christopher Wilcox, MD, PhD (1)  ·  Clyde W Yancy, MD (1)  ·  David R Murray, MD (1)  ·  Dirk H Walter, MD (1)  ·  Divya Gupta, MD (1)  ·  Eric D Adler, MD (1)  ·  Eric KC Wong, MD FRCPC (1)  ·  Erling B Pedersen, Professor (1)  ·  H. Kirk Hammond, MD (1)  ·  Hilton Miller, Professor (1)  ·  Hiroaki Matsubara, MD,PhD (1)

Results publications

PMID 11705426, PMID 22088800, PMID 22936827, PMID 22965994, PMID 22980293, PMID 23122795, PMID 23592107, PMID 24444305, PMID 25187002, PMID 25926562, PMID 26601770, PMID 27221316, PMID 27437887, PMID 29217757, PMID 30258648, PMID 31909303, PMID 33590355, PMID 34405565, PMID 35360224, PMID 41120766

NIH funding

P01HL076611 (3), UL1RR024150 (3), R01HL084155 (2), 2005 (1), 2017 (1), 2019 (1), P01HL066941 (1), R01HL036634 (1), R21DK081877 (1)